When did Immunoprecise Antibodies report Q2 2025 earnings?

Immunoprecise Antibodies (HYFT) reported Q2 2025 earnings on July 29, 2025 before market open.

What were Immunoprecise Antibodies's Q2 2025 revenue and EPS?

Immunoprecise Antibodies reported revenue of $5.1M and diluted EPS of $-0.04 for Q2 2025.

Revenue missed the consensus estimate of $6.4M by $1.3M. EPS missed the consensus estimate of $-0.02 by $0.02.

Compared to the same quarter a year prior, revenue grew 7.0% from $4.7M a year earlier and diluted EPS grew 92.3% from $-0.52.

Reported July 29, 2025 · Before market open

Revenue estimate$6.4M

EPS estimate-$0.02

Jul 23, 2026 (in a month)

Revenue estimate$3.2M

EPS estimate-$0.05

Q2 2025$5.1MMiss by $1.3M

Q2 2025-$0.04Miss by $0.02

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Immunoprecise Antibodies report Q2 2025 earnings?: Immunoprecise Antibodies (HYFT) reported Q2 2025 earnings on July 29, 2025 before market open.
What were Immunoprecise Antibodies's Q2 2025 revenue and EPS?: Immunoprecise Antibodies reported revenue of $5.1M and diluted EPS of $-0.04 for Q2 2025.
Did Immunoprecise Antibodies beat estimates in Q2 2025?: Revenue missed the consensus estimate of $6.4M by $1.3M. EPS missed the consensus estimate of $-0.02 by $0.02.
How did Immunoprecise Antibodies's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 7.0% from $4.7M a year earlier and diluted EPS grew 92.3% from $-0.52.